Search Results

You are looking at 1 - 5 of 5 items for :

  • "glucagon-like peptide-1" x
  • Top-cited articles of 2023 x
  • Refine by access: All content x
Clear All
Wenjuan Liu Department of Endocrinology and Metabolism, Huashan Hospital, Fudan University, Shanghai, China

Search for other papers by Wenjuan Liu in
Google Scholar
PubMed
Close
,
Harry Kevin Lau Division of Endocrinology and Metabolism, The Keenan Research Centre in the Li Ka Shing Knowledge Institute, St. Michael’s Hospital, Toronto, Ontario, Canada

Search for other papers by Harry Kevin Lau in
Google Scholar
PubMed
Close
,
Dong Ok Son Division of Endocrinology and Metabolism, The Keenan Research Centre in the Li Ka Shing Knowledge Institute, St. Michael’s Hospital, Toronto, Ontario, Canada

Search for other papers by Dong Ok Son in
Google Scholar
PubMed
Close
,
Tianru Jin Department of Physiology, University of Toronto, Toronto, Ontario, Canada
Division of Advanced Diagnostics, Toronto General Research Institutes, University Health Network, Toronto, Ontario, Canada
Banting and Best Diabetes Centre, University of Toronto, Toronto, Ontario, Canada

Search for other papers by Tianru Jin in
Google Scholar
PubMed
Close
,
Yehong Yang Department of Endocrinology and Metabolism, Huashan Hospital, Fudan University, Shanghai, China

Search for other papers by Yehong Yang in
Google Scholar
PubMed
Close
,
Zhaoyun Zhang Department of Endocrinology and Metabolism, Huashan Hospital, Fudan University, Shanghai, China

Search for other papers by Zhaoyun Zhang in
Google Scholar
PubMed
Close
,
Yiming Li Department of Endocrinology and Metabolism, Huashan Hospital, Fudan University, Shanghai, China

Search for other papers by Yiming Li in
Google Scholar
PubMed
Close
,
Gerald J Prud’homme Department of Laboratory Medicine and Pathobiology, Keenan Research Centre for Biomedical Science of St. Michael’s Hospital, University of Toronto, Toronto, Ontario, Canada

Search for other papers by Gerald J Prud’homme in
Google Scholar
PubMed
Close
, and
Qinghua Wang Department of Endocrinology and Metabolism, Huashan Hospital, Fudan University, Shanghai, China

Search for other papers by Qinghua Wang in
Google Scholar
PubMed
Close

the β-cell mass and provide improved treatments for T1D and T2D subjects. Glucagon-like peptide-1 (GLP-1) is an incretin hormone released from gastrointestinal L cells in response to food ingestion, and has been currently used for the treatment of T2

Restricted access
Christina Antza Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK
Department of Diabetes and Endocrinology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK

Search for other papers by Christina Antza in
Google Scholar
PubMed
Close
,
Georgios Kostopoulos Department of Endocrinology, 424 General Military Hospital, Thessaloniki, Greece

Search for other papers by Georgios Kostopoulos in
Google Scholar
PubMed
Close
,
Samiul Mostafa Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK
Department of Diabetes and Endocrinology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK

Search for other papers by Samiul Mostafa in
Google Scholar
PubMed
Close
,
Krishnarajah Nirantharakumar Institute of Applied Health Research, University of Birmingham, Birmingham, UK
Centre of Endocrinology Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK

Search for other papers by Krishnarajah Nirantharakumar in
Google Scholar
PubMed
Close
, and
Abd Tahrani Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK
Department of Diabetes and Endocrinology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
Centre of Endocrinology Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK

Search for other papers by Abd Tahrani in
Google Scholar
PubMed
Close

2DM ( Gruden et al. 2016 ). Experimental sleep restriction was also associated with reduction in glucagon-like peptide-1 (GLP-1) in women ( St-Onge et al. 2012 ). These changes in leptin, ghrelin and GLP-1 can contribute to the increase appetite

Open access
Marion Régnier UCLouvain, Université Catholique de Louvain, WELBIO – Walloon Excellence in Life Sciences and BIOtechnology, Louvain Drug Research Institute, Metabolism and Nutrition Research Group, Brussels, Belgium

Search for other papers by Marion Régnier in
Google Scholar
PubMed
Close
,
Matthias Van Hul UCLouvain, Université Catholique de Louvain, WELBIO – Walloon Excellence in Life Sciences and BIOtechnology, Louvain Drug Research Institute, Metabolism and Nutrition Research Group, Brussels, Belgium

Search for other papers by Matthias Van Hul in
Google Scholar
PubMed
Close
,
Claude Knauf Université Paul Sabatier, Toulouse III, INSERM U1220, Institut de Recherche en Santé Digestive (IRSD), CHU Purpan, Place du Docteur Baylac, Toulouse Cedex 3, France
European Associated Laboratory (EAL) ‘NeuroMicrobiota’, Brussels/Toulouse, Belgium

Search for other papers by Claude Knauf in
Google Scholar
PubMed
Close
, and
Patrice D Cani UCLouvain, Université Catholique de Louvain, WELBIO – Walloon Excellence in Life Sciences and BIOtechnology, Louvain Drug Research Institute, Metabolism and Nutrition Research Group, Brussels, Belgium
European Associated Laboratory (EAL) ‘NeuroMicrobiota’, Brussels/Toulouse, Belgium

Search for other papers by Patrice D Cani in
Google Scholar
PubMed
Close

hormones ( Cani et al. 2004 ). Indeed, both oligofructose and inulin have the capacity to reduce dietary intake in rodents by a mechanism that involves anorexigenic and orexigenic gut hormones, that is, an increase in glucagon-like peptide 1 (GLP-1) and

Free access
Robin Kristófi Department of Medical Sciences, Clinical Diabetes and Metabolism, Uppsala University, Uppsala, Sweden

Search for other papers by Robin Kristófi in
Google Scholar
PubMed
Close
and
Jan W Eriksson Department of Medical Sciences, Clinical Diabetes and Metabolism, Uppsala University, Uppsala, Sweden

Search for other papers by Jan W Eriksson in
Google Scholar
PubMed
Close

-phosphate dehydrogenase leading to an increase of cytosolic NAD hydrogen (NADH) levels and altered redox state in hepatocytes. This may also contribute to increased glucagon-like peptide-1 secretion and decreased gluconeogenesis in intestinal cells ( He 2020

Free access
Nicole G Barra Department of Biochemistry and Biomedical Sciences, Department of Biochemistry and Biomedical Sciences, Farncombe Family Digestive Health Research Institute, Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, Ontario, Canada

Search for other papers by Nicole G Barra in
Google Scholar
PubMed
Close
,
Fernando F Anhê Department of Biochemistry and Biomedical Sciences, Department of Biochemistry and Biomedical Sciences, Farncombe Family Digestive Health Research Institute, Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, Ontario, Canada

Search for other papers by Fernando F Anhê in
Google Scholar
PubMed
Close
,
Joseph F Cavallari Department of Biochemistry and Biomedical Sciences, Department of Biochemistry and Biomedical Sciences, Farncombe Family Digestive Health Research Institute, Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, Ontario, Canada

Search for other papers by Joseph F Cavallari in
Google Scholar
PubMed
Close
,
Anita M Singh Department of Biochemistry and Biomedical Sciences, Department of Biochemistry and Biomedical Sciences, Farncombe Family Digestive Health Research Institute, Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, Ontario, Canada

Search for other papers by Anita M Singh in
Google Scholar
PubMed
Close
,
Darryl Y Chan Department of Biochemistry and Biomedical Sciences, Department of Biochemistry and Biomedical Sciences, Farncombe Family Digestive Health Research Institute, Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, Ontario, Canada

Search for other papers by Darryl Y Chan in
Google Scholar
PubMed
Close
, and
Jonathan D Schertzer Department of Biochemistry and Biomedical Sciences, Department of Biochemistry and Biomedical Sciences, Farncombe Family Digestive Health Research Institute, Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, Ontario, Canada

Search for other papers by Jonathan D Schertzer in
Google Scholar
PubMed
Close

gut microbes by increasing SCFA-producing bacteria and mucin-degrading Akkermansia muciniphila while increasing intestinal glucose absorption and glucagon-like peptide-1 production ( McCreight et al. 2016 , Vallianou et al. 2019 ). Although

Free access